Emerging Stocks Down Under 24 May 2022: Microba Life Sciences (ASX:MIO)

Emerging Stocks Down Under 24 May 2022: Microba Life Sciences (ASX:MIO) 2
Microba Life Sciences: It's been gut punched, but can it get back up again?
In recent weeks we’ve taken a look at some of the IPOs that have defied the market and went up in recent months – IPD Group (ASX: IPG), Atturra (ASX: ATA) and Ventia (ASX: VNT) being a few examples. Today we’re dissecting a debutante that has followed the market and we’re asking if it can recover – Microba Life Sciences (ASX: MAP). Microba is a biotech that is seeking to commercialise a technology that helps identify gut health problems. Click here to read the previous edition of Emerging Stocks Down Under published 17 May 2022 For in-depth research reports or to keep up-to-date on the latest Stocks Down Under news see our parent company, Pitt Street Research, or follow us on Facebook and Twitter.
Please register or upgrade your plan to access this content.

Save $$$
30-Day Free Trial
$0
No Credit Card Required!
Get access to 5 publications per week
Weekly Investor Webinar
Profit Premium
$69
Get access to 5 publications per week
Access to the full research Archive
Weekly Investor Webinar
30-Day Free Trial
$0
No Credit Card Required!
Get access to 5 publications per week
Weekly Investor Webinar
Profit Premium
$59
BILLED ANNUALLY
Get access to 5 publications per week
Access to the full research Archive
Weekly Investor Webinar